Bluejay Diagnostics Past Earnings Performance
Past criteria checks 0/6
Bluejay Diagnostics's earnings have been declining at an average annual rate of -55.6%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 42.9% per year.
Key information
-55.6%
Earnings growth rate
-11.9%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 42.9% |
| Return on equity | -343.8% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How Bluejay Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -10 | 5 | 6 |
| 30 Sep 23 | 0 | -10 | 5 | 6 |
| 30 Jun 23 | 0 | -11 | 5 | 6 |
| 31 Mar 23 | 0 | -10 | 5 | 5 |
| 31 Dec 22 | 0 | -9 | 5 | 4 |
| 30 Sep 22 | 0 | -8 | 5 | 3 |
| 30 Jun 22 | 0 | -7 | 4 | 2 |
| 31 Mar 22 | 0 | -5 | 3 | 2 |
| 31 Dec 21 | 0 | -3 | 2 | 1 |
| 30 Sep 21 | 0 | -3 | 1 | 1 |
| 30 Jun 21 | 0 | -2 | 1 | 1 |
| 31 Mar 21 | 0 | -1 | 1 | 0 |
| 31 Dec 20 | 0 | -1 | 1 | 1 |
Quality Earnings: BJDX is currently unprofitable.
Growing Profit Margin: BJDX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BJDX is unprofitable, and losses have increased over the past 5 years at a rate of 55.6% per year.
Accelerating Growth: Unable to compare BJDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BJDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: BJDX has a negative Return on Equity (-343.85%), as it is currently unprofitable.